Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

NCT01306214 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

566

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Obesity

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: BI 10773
DRUG: BI 10773

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]